Exclusive-Germany's Merck KGaA in talks to buy US biotech firm Springworks, sources say
Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases ...
FiercePharma2h
Merck KGaA sets its sights on acquisition of Ogsiveo-maker SpringWorks: Reuters
As SpringWorks Therapeutics nears a key regulatory decision in the U.S., the Connecticut-based cancer and rare disease ...
Exclusive-Germany's Merck KGaA in talks to buy US cancer biotech firm Springworks, sources say
Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases ...
Merck KGaA in Talks to Buy SpringWorks Therapeutics
Merck KGaA is in advanced talks to buy US cancer and rare diseases drugmaker SpringWorks Therapeutics Inc., according to a ...
devdiscourse2h
Merck KGaA Eyes Major U.S. Acquisition: Springworks Therapeutics on the Brink
German healthcare giant Merck KGaA is in advanced talks to acquire U.S.-based Springworks Therapeutics, known for cancer and rare disease treatments. The potential acquisition would enhance Merck's ...
Merck & Co. (MRK): ‘Forget It… It’s China,’ Jim Cramer on Vaccine Rollout Woes
We recently published a list of Jim Cramer Discussed These 12 Stocks Recently. In this article, we are going to take a look ...